SRx Health closes $7.3M convertible note financing and secures $50M equity line of credit

SRx Health Solutions, Inc.

Closed $7.3M convertible note financing led by insiders and existing investors; notes bear 8% interest, mature July 2027.
Notes convertible at $0.6274 per share; warrants issued to purchase 21,338,062 shares at $0.6274, exercisable for 3 years.
Secured $50M equity line of credit (ELOC) with a lead investor; $1M in commitment shares issued at a discount to market.
Proceeds to support U.S. M&A pipeline, Canadian specialty pharma expansion, and working capital for growth initiatives.
Company granted security interest in substantially all U.S. business assets as collateral for the note financing.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.